Bicycle Therapeutics plc (BCYC) Tops Q1 EPS by 63c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q1 EPS of ($0.62), $0.63 better than the analyst estimate of ($1.25). Revenue for the quarter came in at $19.53 million versus the consensus estimate of $6.07 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Reading (RDI) Tops Q2 EPS by 4c